As of May 2012, Vietnam continues to see sustained high incidence of hand, foot and mouth disease (HFMD) since the beginning of the year. China, Hong Kong (China), Macao (China) and Singapore have been reporting an increase in number of cases.
ECDC, through the VBORNET network, publishes regularly on its website maps on exotic mosquitoes and on phlebetomines - to provide the ECDC stakeholders and the general public with the most updated information on vector distribution. The maps are updated and improved quarterly.
This study found a marked reduction in vaccine serotype carriage after PCV7 implementation. The overall pneumococcal, H. influenzae and S. aureus carriage decreased slightly, but not significantly.
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published the second joint EU report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and food.
The European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC) have published their annual report on zoonoses and food-borne outbreaks in the European Union for 2010.
A meeting and a workshop on the ECDC point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use in acute care hospitals took take place in London on 5-6 March 2012.
The coordination of European FWD outbreaks can be difficult to manage. In order to help Member State countries with the task, ECDC is launching an online toolkit which provides investigators with a series of tools for the investigation of an outbreak that involves at least two EU Member States.
This study demonstrates that PCV13 is immunogenic and safe in children previously vaccinated with PCV7. By eliciting high antibacterial immune responses to the additional serotypes, PCV13 provides protection against these serotypes, which are important causes of pneumococcal disease globally.